SCHEMBL3076150

SCHEMBL3076150

Cc1nc(-c2ccccn2)sc1C(=O)Cl

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.76
ALDH1A1 P00352 6/20 0.76
KMT2A Q03164 4/20 0.76
GAA P10253 2/20 0.72
LMNA P02545 1/20 0.67
MAPT P10636 4/20 0.60
HPGD P15428 2/20 0.60
POLB P06746 1/20 0.60
RAB9A P51151 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.48
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
NPC1 O15118 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GFER P55789 1/20 0.46
PDE10A Q9Y233 1/20 0.45
ATM Q13315 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL596082 0.87 KDM4E (1.00) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL29783027 0.87 ALDH1A1 (1.00) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL1574901 0.87 ALDH1A1 (1.00) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL7063637 0.85 KDM4E (0.76) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL1312946 0.83 LMNA (0.76) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL20646835 0.83 KDM4E (0.72) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL20646838 0.83 ALDH1A1 (0.72) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL28364602 0.81 LMNA (1.00) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL192423 0.79 CDC7 (0.56) KDM4EALDH1A1KMT2AGAALMNA
SCHEMBL5726852 0.79 KDM4E (0.59) KDM4EALDH1A1KMT2AGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790723-B2 Thiazole derivatives as phosphodiesterase IV inhibitors MERCK PATENT GMBH (DE) 2010-09-07 US disclosed
US-20050222160-A1 Thiazole derivatives as phosphodiesterase iv inhibitors MERCK PATENT GMBH (DE) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222160-A1 Thiazole derivatives as phosphodiesterase iv inhibitors PDE3B, PDE4B, PDE4A KDM4E 1126/4885ALDH1A1 1542/4885KMT2A 3040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.